T. Rowe Price Biotech ETF (TDNA) price, chart and fund profile
Price chart
Fund profile
TDNA seeks to provide long-term capital appreciation.
- Issuer
- T. Rowe Price Associates, Inc.
- Industry
- —
- Inception
- Sep 16, 2026
- Expense ratio
- 0.55%
- Net asset value
- $24.57
- NAV as of
- Oct 2, 2026
- Leverage
- 1×
- Fund page
- www.troweprice.com↗
Frequently asked questions
What is T. Rowe Price Biotech ETF (TDNA)?
TDNA seeks to provide long-term capital appreciation.
What is TDNA's expense ratio?
T. Rowe Price Biotech ETF charges an annual expense ratio of 0.55%. The fund is issued by T. Rowe Price Associates, Inc..
How large is TDNA?
T. Rowe Price Biotech ETF manages $9.8M in assets and has traded since Sep 16, 2026.
How do I buy shares of T. Rowe Price Biotech ETF (TDNA)?
TDNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.